Diagnosis and management of heart failure in the outpatient setting

Primary Care - Clinics in Office Practice

Volumn 32, Issue 4, 2005, Pages 1115-1129

  Wilbur, Jason ^a   James, Paul ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; MORPHINE; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DYSPNEA; GYNECOMASTIA; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; KIDNEY PERFUSION; LABORATORY TEST; OUTPATIENT DEPARTMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SODIUM INTAKE; UREMIA;

ADRENERGIC BETA-ANTAGONISTS; AMBULATORY CARE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DISEASE PROGRESSION; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; PALLIATIVE CARE; PRIMARY HEALTH CARE; PROGNOSIS;

EID: 28444447350     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2005.09.005     Document Type: Review

References (43)

1. American Heart Association Heart disease and stroke statistics 2005 update 2005 American Heart Association Dallas (TX) Available at: http://www.americanheart.org Accessed April 3, 2005
2. V.L. Roger, S.A. Weston, and M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 3 2004 344 350
3. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure [see comment] N Engl J Med 347 18 2002 1397 1402
4. G.S. Francis, S.R. Goldsmith, and T.B. Levine The neurohormonal axis in congestive heart failure Ann Intern Med 101 3 1984 370 377
5. I. Mansi, J. Huang, and D. Carden Pharmacologic treatment of chronic systolic heart failure: past, present, and future Advanced Studies in Medicine 5 2 2005 81 89
6. M.R. Zile, C.F. Baicu, and W.H. Gaasch Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle [see comment] N Engl J Med 350 19 2004 1953 1959
7. G.P. Aurigemma, and W.H. Gaasch Clinical practice. Diastolic heart failure [see comment] N Engl J Med 351 11 2004 1097 1105
8. P.A. MacCarthy, M.T. Kearney, and J. Nolan Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study BMJ 327 7406 2003 78 79
9. G.L. Smith, F.A. Masoudi, and V. Vaccarino Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline [see comment] J Am Coll Cardiol 41 9 2003 1510 1518
10. D.D. Tresch The clinical diagnosis of heart failure in older patients [see comment] J Am Geriatr Soc 45 9 1997 1128 1133
11. A.P. Davie, L. Caruana, and G.R. Sutherland Assessing diagnosis in heart failure: which features are any use? Q J Med 90 1997 335 339
12. S. Morgan, H. Smith, and I. Simpson Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey BMJ 318 1999 368 372
13. S.A. Dosh Diagnosis of heart failure in adults Am Fam Physician 70 11 2004 2145 2152
14. M. Di Bari, C. Pozzi, and M.C. Cavallini The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study J Am Coll Cardiol 44 8 2004 1601 1608
15. R.G. Badgett, C.R. Lucey, and C.D. Mulrow Can the clinical examination diagnose left-sided heart failure in adults? [see comment] JAMA 277 21 1997 1712 1719
16. M. Senni, C.M. Tribouilloy, and R.J. Rodeheffer Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 21 1998 2282 2289
17. M. Rich Office management of heart failure in the elderly Am J Med 118 2005 342 348
18. K. Maeda, T. Tsutamoto, and A. Wada Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
19. R. Cardarelli, and T.G. Lumicao Jr. B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians J Am Board Fam Pract 16 4 2003 327 333
20. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure [see comment] N Engl J Med 347 3 2002 161 167 Summary for patients in J Fam Pract 2002;51(10):816
21. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 7 2001 2101 2113
22. M.F. Piepoli, C. Davos, and D.P. Francis Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) [see comment] BMJ 328 7433 2004 189
23. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 227
24. H.M. Krumholz, J. Amatruda, and G.L. Smith Randomized trial of an education and support intervention to prevent readmission of patients with heart failure [see comment] J Am Coll Cardiol 39 1 2002 83 89
25. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials [see comment] [published correction appears in JAMA 1995;274(6):462] JAMA 273 18 1995 1450 1456
26. S. Yusuf, P. Sleight, and J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 3 2000 145 153
27. P. Jong, S. Yusuf, and M.F. Rousseau Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Lancet 361 9372 2003 1843 1848
28. P. Jong, C. Demers, and R.S. McKelvie Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials [see comment] J Am Coll Cardiol 39 3 2002 463 470
29. J.M. Brophy, L. Joseph, and J.L. Rouleau Beta-blockers in congestive heart failure. A Bayesian meta-analysis Ann Intern Med 134 7 2001 550 560
30. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators [see comment] N Engl J Med 341 10 1999 709 717
31. B. Bozkurt, I. Agoston, and A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines [see comment] J Am Coll Cardiol 41 2 2003 211 214
32. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [see comment] [published correction appears in N Engl J Med 2003;348(22):2271] N Engl J Med 348 14 2003 1309 1321
33. D.C. Brater Diuretic therapy N Engl J Med 339 6 1998 387 395
34. B.K. Kramer, F. Schweda, and G.A. Riegger Diuretic treatment and diuretic resistance in heart failure Am J Med 106 1 1999 90 96
35. Anonymous The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group [see comment] N Engl J Med 336 8 1997 525 533
36. A.L. Taylor, S. Ziesche, and C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure [see comment] [published correction appears in N Engl J Med 2005;352(12):1276] N Engl J Med 351 20 2004 2049 2057
37. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial [see comment] Lancet 362 9386 2003 777 781
38. E.H. Wagner, R.E. Glasgow, and C. Davis Quality improvement in chronic illness care: a collaborative approach Jt Comm J Qual Improv 27 2 2001 63 80
39. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness JAMA 288 14 2002 1775 1779
40. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness: the chronic care model, part 2 JAMA 288 15 2002 1909 1914
41. M. Rich, V. Beckham, and C. Wittenberg A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 18 1995 1190 1195
42. J. Ayanian, M.B. Landrum, and E. Guadagnoli Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction N Engl J Med 347 21 2002 1678 1686
43. A.D. Auerbach, M.B. Hamel, and R.M. Califf Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments J Am Coll Cardiol 36 7 2000 2119 2125